Komboglyze 2.5 mg (Saxagliptin (Saxagliptin Hydrochloride) TABLET) 2.5 MG

KOMBOGLYZE 2.5 MG tablets contain saxagliptin hydrochloride, a diabetes medication used to control blood sugar levels. This oral tablet is manufactured by AstraZeneca Canada Inc. and is commonly prescribed as part of a broader diabetes management plan.

Strength

2.5 MG

Pack Size

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KOMBOGLYZE 2.5 MG tablets are primarily used to manage type 2 diabetes in adults. Saxagliptin works by increasing the levels of incretin hormones, which help the pancreas release insulin in response to food intake. This medication is often used alongside diet and exercise to improve glycemic control. People often ask, 'What is saxagliptin used for?' and the answer is that it is used to help manage blood sugar levels in people with type 2 diabetes.

Side Effects

Common effects of KOMBOGLYZE 2.5 MG tablets may include headache, upper respiratory tract infection, and nasopharyngitis. Some users may also experience gastrointestinal issues such as nausea or diarrhea. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

KOMBOGLYZE 2.5 MG tablets should be handled with care, especially by individuals with a history of kidney problems or pancreatitis. It is important to follow the advice of a healthcare provider regarding the use of this medication. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

KOMBOGLYZE 2.5 MG tablets may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect blood sugar levels.

Frequently Asked Questions

KOMBOGLYZE 2.5 MG tablets are used to manage type 2 diabetes by helping to control blood sugar levels.

KOMBOGLYZE 2.5 MG tablets are taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include headache, upper respiratory tract infection, and gastrointestinal issues like nausea or diarrhea.

It is important to consult a healthcare provider before taking KOMBOGLYZE 2.5 MG with other medications to avoid potential interactions.

KOMBOGLYZE 2.5 MG may not be suitable for everyone, especially those with a history of kidney problems or pancreatitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.